Well-Being After Breast Cancer Surgery
WB ABCs
Improving Well-Being for Individuals With Persistent Pain After Surgery for Breast Cancer, Lobular Carcinoma in Situ, or Ductal Carcinoma in Situ: A Randomized Clinical Trial That Compares Three Behavioral Intervention Strategies and Examines Psychological Factors as Drivers of the Continuing Burden of Persistent Pain
1 other identifier
interventional
316
1 country
2
Brief Summary
The purpose of this study is to compare the benefits of skills training and health education interventions designed specifically to increase the well-being of people with persistent pain after breast surgery for lobular carcinoma in situ (LCIS), ductal carcinoma in situ (DCIS), or invasive breast cancer, and to examine the roles of psychological and physiological variables as modifiable contributors to the continuing burden of persistent pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2021
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 3, 2020
CompletedFirst Posted
Study publicly available on registry
January 13, 2020
CompletedStudy Start
First participant enrolled
June 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 11, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 11, 2026
CompletedMarch 27, 2026
February 1, 2026
4.8 years
January 3, 2020
March 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in PEG Pain Severity and Interference
Persistent post-surgical pain burden 3-item measure: average pain intensity (P); interference with enjoyment in life (E); interference with general activity (G)
Baseline, 3 months, 6 months, 12 months
Secondary Outcomes (4)
Change in emotional distress: Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS)
Baseline, 3 months, 6 months, 12 months
Change in pain catastrophizing: Pain Catastrophizing Scale (PCS)
Baseline, 3 months, 6 months, 12 months
Change in Central sensitization: Central Sensitization Inventory (CSI)
Baseline, 3 months, 6 months, 12 months
Change in Central sensitization: Temporal summation
Baseline, 6 months, 12 months
Other Outcomes (5)
Change in cancer-specific distress: Impact of Event Scale (IES)
Baseline, 3 months, 6 months, 12 months
Change in psychological inflexibility: Acceptance and Action Questionnaire (AAQ-II)
Baseline, 3 months, 6 months, 12 months
Change in self-efficacy: Chronic Pain Self-Efficacy Scale: Function Self-Efficacy Subscale (FSE)
Baseline, 3 months, 6 months, 12 months
- +2 more other outcomes
Study Arms (3)
Coping Skills Training for Persistent Post-Surgical Pain
EXPERIMENTALnovel pain coping skills training intervention designed specifically for people with persistent pain (PP) following breast cancer surgery
General health education with a coach
ACTIVE COMPARATORgeneral health education intervention
Self-guided health education
ACTIVE COMPARATORgeneral health education intervention
Interventions
skills training and experiential learning exercises
general health education intervention that focuses on improving overall health
Eligibility Criteria
You may qualify if:
- prior diagnosis of Stage 0 to III breast cancer, DCIS or LCiS
- received first breast cancer surgery (total or partial mastectomy, lumpectomy) at least 3 months ago
- reports score of ≥3 in the past month on the 0 to 10 breast pain severity and/or interference scale
- able to speak and read English
- able to provide meaningful consent
You may not qualify if:
- \<18 years of age
- hearing impairment that limits use of videoconferencing for intervention sessions
- cognitive impairment that is documented in the medical record or results in being unable to provide meaningful consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- University of Pittsburgh Medical Centercollaborator
Study Sites (2)
Duke University Medical Center
Durham, North Carolina, 27705, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15232, United States
Related Publications (1)
Stalls JM, Bovbjerg DH, Somers TJ, Plumb Vilardaga JC, Kimmick GG, McAuliffe PF, Keefe FJ, Posluszny DM, Sullivan MJL, Erkanli A, Reed SD, Sutton L, Owen L, Massa L, Shelby RA. Improving well-being for individuals with persistent pain after surgery for breast cancer, lobular carcinoma in situ, or ductal carcinoma in situ: A randomized clinical trial. Contemp Clin Trials. 2022 Nov;122:106934. doi: 10.1016/j.cct.2022.106934. Epub 2022 Sep 21.
PMID: 36152791DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Rebecca Shelby, PhD
Duke University
- PRINCIPAL INVESTIGATOR
Dana Bovbjerg, PhD
University of Pittsburgh Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Study staff conducting assessments will be blind to group assignment. To maintain blinding, we will use the following approaches: 1) all study staff will be trained on the importance of blinding and study procedures to maintain blinding; 2) participants will be provided with the rationale and instructions not to disclose their group assignment; 3) the study staff who conduct post-intervention assessments will not be given information about group assignment prior to the assessment; and 4) if a breach occurs, it will be documented and the participant will complete their assessment with a new assessor.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 3, 2020
First Posted
January 13, 2020
Study Start
June 8, 2021
Primary Completion
March 11, 2026
Study Completion
March 11, 2026
Last Updated
March 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share